Procedures While Wearing CBRNe Protective Equipment
Primary Purpose
Cardiac Arrest, Pneumothorax, Hemorrhage
Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Use of Personal Protective Equipment
Sponsored by
About this trial
This is an interventional health services research trial for Cardiac Arrest
Eligibility Criteria
Inclusion Criteria:
- Senior Emergency Medicine (EM) and Anesthesiology and Critical Care (ACC) residents (PGY-4 and -5) from the residency programs of the University of Padova (Padova, Italy)
Exclusion Criteria:
- not giving informed consent
- not willing to participate
Sites / Locations
- SIMULARTI Simulation Centre
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Personal Protective Equipment
NO-Personal Protective Equipment
Arm Description
Wearing: Tyvek pro-tech® "C" gear (Bonetti, Milano, Italy), a full visor SGE 400 mask (EN 136:98 CL3) connected to an A2B2E2K2-P3 R filter (Spasciani, Milano, Italy), and well-fitting, non-sterile Mapa Ultranitril 480 gloves (Mapa SAS, Colombes, France).
only wearing well-fitting, medical examination nitrile gloves.
Outcomes
Primary Outcome Measures
chest compressions
difference in sternum to spine chest compressions depth during CPR
Secondary Outcome Measures
average rates
differences in chest compressions average rates per minute during CPR
chest full release
differences in percentage of chest compressions full release during CPR
tourniquet positioning
differences in times for completion of tourniquet positioning
pneumothorax decompression
differences in times for completion of pneumothorax decompression
venous catheter positioning
differences in times for the positioning of a peripheral venous catheter
intraosseous access positioning
differences in times for the positioning of an intraosseous access
drug preparation and administration
differences in times for drug preparation and administration
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04367454
Brief Title
Procedures While Wearing CBRNe Protective Equipment
Official Title
Life-Saving Procedures Performed in the Pre-Decontamination Area While Wearing CBRNe Personal Protective Equipment: A Manikin Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
April 2020
Overall Recruitment Status
Completed
Study Start Date
August 1, 2019 (Actual)
Primary Completion Date
September 1, 2019 (Actual)
Study Completion Date
September 30, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Padova
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Out-of-hospital care during Chemical-Biological-Radiological-Nuclear-explosive (CBRNe) events have recently evolved, but the available knowledge is still extremely partial. In particular, the debate is still ongoing regarding which life-saving maneuvers should be implemented in the pre-decontamination phase while wearing CBRNe personal protective equipment (PPE). The investigators hypothesized that PPE may lengthen the execution times and worsen the success rate of invasive and non-invasive procedures.
This trial involves residents in emergency medicine and anesthesia/critical care of the University of Padova (Italy) with the following procedures performed on high-fidelity manikins, after being divided into two groups (wearing and not wearing PPE): positioning of peripheral venous access; intraosseous access; drug preparation and administration; tension pneumothorax (PNX) needle decompression; tourniquet positioning; chest compressions. The primary outcome was the chest compressions depth mean difference between the two groups. As secondary outcomes, the investigators measured differences between the two groups in: the percentages of correct release during chest compressions; chest compressions rate (beats per minute); and the times needed to complete the above-mentioned procedures (other than chest compressions).
The investigators expect that PPE will reduce CPR quality or delay the completion of the procedures.
Detailed Description
This is a single-center, randomized (1:1), parallel-group, manikin trial comparing times of execution and quality of life-saving procedures performed by residents while wearing PPE for CBRNe events versus no PPE. The trial was deemed exempt from review by the local Ethics Committee (No. 0045954/2019). The study was conducted aiming to reduce carbon footprint and increase sustainability.
Study Population The trial involves Senior Emergency Medicine (EM) and Anesthesiology and Critical Care (ACC) residents (PGY-4 and -5) from the residency programs of the University of Padova (Padova, Italy), recruited via email by the study coordinator (GM) without selection. Eligible residents are certified as proficient at the procedures described in the next section by the respective residency board, being this a prerequisite to qualify as a PGY-4 and -5 in Italy. The subjects participating in the study don't receive any incentives. Written consent is asked prior to the beginning. The study is organized at the "SIMULARTI" medical simulation center of the University of Padova in Padova, Italy.
Interventions and Procedures Residents are involved in performing the following procedures on the ground on high fidelity manikins: two rescuers CPR (SUSIE - Gaumard Scientific, Miami, FL); tactical tourniquet application (with a Combat Application Tourniquet®, CAT Resources, Rock Hill, SC; on a Trauma Hal - Gaumard Scientific, Miami, FL); tension PNX needle decompression (Truman Trauma X - TruCorp, Lurgan, N. Ireland); positioning of peripheral venous access, intraosseous vascular access (with EZ-IO® - Teleflex, Wayne, PA), and drug preparation and administration (Code Blue III Adult - Gaumard Scientific, Miami, FL). Each procedure is accomplished by the algorithms collected in an operations manual made available to the researchers only, and verbally disclosed to the participants before their attempt (see Online Supplement 1). The participants do not receive any feedback, neither verbal nor visual, during the execution of the procedures. Subjects in the intervention group wear a Tyvek pro-tech® "C" gear (Bonetti, Milano, Italy), a full visor SGE 400 mask (EN 136:98 CL3) connected to an A2B2E2K2-P3 R filter (Spasciani, Milano, Italy), and well-fitting, non-sterile Mapa Ultranitril 480 gloves (Mapa SAS, Colombes, France). Subjects in the control group only wear well-fitting, medical examination nitrile gloves.
After the end of the procedures under investigation, participants from the control group are given the possibility to perform the procedures wearing CBRNe PPE, since this is a training session part of their curricular activities. Finally, an anonymous questionnaire was administered to the participants to evaluate their perception of the experience (Online Supplement 2). The questionnaire was composed of 10 items - 7 positive and 3 negative - that participants had to rate using a 5 point Likert scale (1=totally disagree; 2=disagree; 3=uncertain; 4=agree; 5=totally agree). The internal consistency of the questionnaire was measured using Cronbach's alfa.
Randomization For the 1:1 allocation of the residents, a computer-generated list of random numbers is used. Participants are randomly assigned following variable block sizes of 2 and 4 to either the intervention group (in which they wore CBRNe PPEs) or to a control group (in which they used only one pair of nitrile gloves) (Figure 1). Also, the participants perform each procedure in a random order according to a computer-generated sequence. Randomization is prepared by a researcher not directly involved with the experiments. The allocation of subjects and order of the procedures are concealed by using sequentially numbered, opaque, stapled envelopes, and upheld until each participant was in the simulation rooms. The experiment coordinator (MP) opens the envelopes and assigns participants to group and procedures. Blinding of participants and researchers involved in the experiment is unfortunately not possible. Only the outcome assessor and data analyst (SS) is kept blinded to the allocation.
Outcomes The primary outcome is the difference in sternum to spine chest compressions (CCs) depth during CPR between the two groups. Secondary outcomes are the differences in CCs average rates per minute, percentage of CCs full release, times for completion of tourniquet positioning, PNX decompression, positioning of a peripheral venous catheter and intraosseous access, and drug preparation and administration. As tertiary outcome, the overall participants' perception of this CBRNe simulated training at the end of the session is measured.
Data Collection In each scenario, a researcher collects times with a stopwatch and monitors the correct execution of procedures. In case of errors, the participant is stopped and granted a second attempt, but is excluded from the study. As for CPR, data are collected using UNI® Unified Simulator Control Software ver 2.41.1.0 (Gaumard Scientific, Miami, FL).
Sample Size and Statistical Analysis The investigators calculated that group sample sizes of 18 and 18 would be required to detect a difference of 5.0 mm in CCs depth with a standard deviation (SD) of 5.0 mm, at a significance level (alpha) of 0.05 and at least 80% power, using a two-sided Mann-Whitney test, assuming that the actual distribution could be non-normal. Qualitative data are analyzed descriptively through their distribution frequency. Quantitative data are tested with a Shapiro-Wilk test for normality. Results are presented as mean with SD, and differences tested with independent t-test in case of normally distributed data with equal variance (tested with Levene's test; if not true: Welch test). Otherwise, results are presented as median and interquartile range (IQR), and differences are tested using a Mann-Whitney test. All tests are two-sided and p values <0.05 are considered statistically significant. An estimated difference with 95% confidence interval (CI) is reported for the difference between testing conditions. Statistical software JASP (ver 0.11.1; JASP Team, 2019) is used to analyze the results.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiac Arrest, Pneumothorax, Hemorrhage
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
single-center, randomized (1:1), parallel-group, manikin trial
Masking
Outcomes Assessor
Masking Description
Blinding of participants and researchers involved in the experiment is not possible. Only the outcome assessor and data analyst (SS) is kept blinded to the allocation of subjects.
Allocation
Randomized
Enrollment
36 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Personal Protective Equipment
Arm Type
Experimental
Arm Description
Wearing: Tyvek pro-tech® "C" gear (Bonetti, Milano, Italy), a full visor SGE 400 mask (EN 136:98 CL3) connected to an A2B2E2K2-P3 R filter (Spasciani, Milano, Italy), and well-fitting, non-sterile Mapa Ultranitril 480 gloves (Mapa SAS, Colombes, France).
Arm Title
NO-Personal Protective Equipment
Arm Type
No Intervention
Arm Description
only wearing well-fitting, medical examination nitrile gloves.
Intervention Type
Other
Intervention Name(s)
Use of Personal Protective Equipment
Intervention Description
As described in the arm descriptions
Primary Outcome Measure Information:
Title
chest compressions
Description
difference in sternum to spine chest compressions depth during CPR
Time Frame
during procedures
Secondary Outcome Measure Information:
Title
average rates
Description
differences in chest compressions average rates per minute during CPR
Time Frame
during procedures
Title
chest full release
Description
differences in percentage of chest compressions full release during CPR
Time Frame
during procedures
Title
tourniquet positioning
Description
differences in times for completion of tourniquet positioning
Time Frame
during procedures
Title
pneumothorax decompression
Description
differences in times for completion of pneumothorax decompression
Time Frame
during procedures
Title
venous catheter positioning
Description
differences in times for the positioning of a peripheral venous catheter
Time Frame
during procedures
Title
intraosseous access positioning
Description
differences in times for the positioning of an intraosseous access
Time Frame
during procedures
Title
drug preparation and administration
Description
differences in times for drug preparation and administration
Time Frame
during procedures
Other Pre-specified Outcome Measures:
Title
Questionnaire
Description
overall participants' perception of the CBRNe simulated training, on a 5 points Likert scale from a minimum of 1 (completely disagree) to a maximum of 5 (completely agree).
Time Frame
At the end of the simulations (about 3 hours after the beginning)
10. Eligibility
Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Senior Emergency Medicine (EM) and Anesthesiology and Critical Care (ACC) residents (PGY-4 and -5) from the residency programs of the University of Padova (Padova, Italy)
Exclusion Criteria:
not giving informed consent
not willing to participate
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fabrizio Fabris, MD
Organizational Affiliation
University of Padova
Official's Role
Study Chair
Facility Information:
Facility Name
SIMULARTI Simulation Centre
City
Padova
State/Province
Veneto
ZIP/Postal Code
35128
Country
Italy
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Upon request
IPD Sharing Time Frame
One year after publication
IPD Sharing Access Criteria
Upon request
Citations:
PubMed Identifier
33428358
Citation
Mormando G, Paganini M, Alexopoulos C, Savino S, Bortoli N, Pomiato D, Graziano A, Navalesi P, Fabris F. Life-Saving Procedures Performed While Wearing CBRNe Personal Protective Equipment: A Mannequin Randomized Trial. Simul Healthc. 2021 Dec 1;16(6):e200-e205. doi: 10.1097/SIH.0000000000000540.
Results Reference
derived
Learn more about this trial
Procedures While Wearing CBRNe Protective Equipment
We'll reach out to this number within 24 hrs